Dr. Nicholas Matthew Bernthal, MD

Dr. Bernthal practices at Orthopaedic Hospital in Los Angeles, California.

Dr. Bernthal's NPI, 1902068356, was assigned on June 26, 2008. Dr. Bernthal graduated from Weill Cornell Medicine in 2006. Dr. Bernthal holds California license A103272.

Dr. Bernthal's primary practice is Orthopaedic Hospital, at 403 W Adams Blvd, Los Angeles, CA 90007 in Los Angeles County. The practice phone is (213) 742-1000.

Dr. Bernthal's primary practice is Orthopaedic Hospital in Los Angeles, California. Dr. Bernthal is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Orthopaedic Surgery. Dmand AI also links Dr. Bernthal to 1 more hospital, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bernthal practices, 3 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Bernthal's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Bernthal is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Bernthal's licenses on file in 3 states: California, Nevada and Utah.

Dmand AI lists amputation, arthritis, joint pain, muscle pain, fibromyalgia, and limb pain, orthopedic surgery of arms and legs and pelvic and hip fracture among the conditions Dr. Bernthal treats.

CMS data shows 204 Medicare services from Dr. Bernthal across 3 procedure codes in 2024, all of them office visits, for 149 Medicare patients. Medicare paid $23,957 for them. Every service was in an office.

CMS counts 149 Medicare patients who saw Dr. Bernthal in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 23% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bernthal's median patient age at 47, with 51% women.

In 2024, Dr. Bernthal wrote 14 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $98 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Bernthal for performance year 2024, reported as part of a group. Dr. Bernthal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bernthal as offering telehealth.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 91 papers to Dr. Bernthal, published from 2010 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Giant Cell Tumor of Tendon Sheath, Disease Models, Animal and Prosthesis-Related Infections. Dr. Bernthal has published most often in J Bone Joint Surg Am. Dr. Bernthal's most frequent co-authors are Robert Lawrence Randall, MD, Stephen Douglas Zoller, MD and Howard Y. Park, MD.

CMS Open Payments shows 264 general payments to Dr. Bernthal from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 86% of the total. Daiichi Sankyo Inc. paid the most, $212,221. It also lists 2 research payments totaling $456,138 from 2021 to 2022.

Dmand AI lists 1 award for Dr. Bernthal.

Dr. Bernthal graduated from Weill Cornell Medicine in 2006.

Dr. Bernthal is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.